Par Drugs and Chemicals Ltd banner

Intrinsic Value

The intrinsic value of Par Drugs and Chemicals Ltd (PAR) under the Base Case is 111.82 INR per share. Compared with the current market price of 118.11 INR, the stock appears Overvalued by 5% .

The intrinsic value is calculated using the DCF method. The model mostly extends the recent record: revenue grows about 10% a year over the next five years, against 11% over the last five, and net margin stays near last year's 13%. If revenue grew at its five-year pace of 11%, the estimate would be about ₹124.

Do our valuations actually work? See backtest results .

PAR Intrinsic Value
₹111.82
Overvaluation 5%
Intrinsic Value
Price ₹118.11
Alert me when PAR is below its intrinsic value
Today ₹89.45 · 24.3% below the current price

PAR is valued in line with its history. A premium of this size has been typical over the past 5 years.

Alternatives to PAR

Fundamental Analysis

What Par Drugs and Chemicals Does

Pharmaceuticals Health Care

Par Drugs and Chemicals makes pharmaceutical ingredients and chemical intermediates that are used to produce medicines. Its products sit early in the drug supply chain, so it sells mainly to other pharma companies rather than directly to patients. The company also serves customers that need custom-made chemical batches for specific drug formulas.

Headquarters
India IN
IPO date
May 16, 2019
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Par Drugs and Chemicals Ltd

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one PAR stock?

The intrinsic value for Par Drugs and Chemicals Ltd (PAR) under the Base Case is 111.82 INR.

Is PAR stock undervalued or overvalued?

Compared with the current market price of 118.11 INR, the stock appears Overvalued by 5% .

Back to Top